Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

FDA approves Nicotrol for OTC marketing

July 12, 1996

Alza/HMR and Ciba-Geigy resolve nicotine patch patent disputes

July 5, 1996

AS-300 and N-CBM-TAMO: Potential agents for treating drug addiction

June 21, 1996

Rockefeller reports new lead in the search for a treatment for cocaine addiction

May 17, 1996

Cocaine vaccine created by ImmuLogic

May 17, 1996

Campral EC now available in U.K.

May 10, 1996

Nehydrin improves cognitive recovery during alcohol withdrawal

May 10, 1996

Ibogaine development to be discussed at international meeting

May 3, 1996

DynaGen's lobeline transdermal system receives patent coverage

May 3, 1996

OTC approval for Nicoderm

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.